Clinical trial
Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients
NCT05329415 is registered in ClinicalTrials.gov with London North West Healthcare NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients
- Lead sponsor
- London North West Healthcare NHS Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2022
- Completion date
- May 31, 2024
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.